Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

被引:84
作者
Adi, Handoko [1 ]
Young, Paul M. [1 ]
Chan, Hak-Kim [1 ]
Agus, Helen [2 ]
Traini, Daniela [1 ]
机构
[1] Univ Sydney, Adv Drug Delivery Grp, Fac Pharm A15, Sydney, NSW 2006, Australia
[2] Univ Sydney, Fac Sci G08, Sydney, NSW 2006, Australia
关键词
Mannitol; Ciprofloxacin; Dry powder inhaler (DPI); Cystic fibrosis; Antibiotics; Mucolytics; RECOMBINANT HUMAN DNASE; HIGH-DOSE IBUPROFEN; PSEUDOMONAS-AERUGINOSA; N-ACETYLCYSTEINE; LUNG-FUNCTION; MUCUS CLEARANCE; INHALATION; ANTIBIOTICS; SAFETY; INFECTION;
D O I
10.1016/j.ejps.2010.03.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to assess the potential of delivering a combination therapy, containing mannitol (a sugar alcohol with osmotic characteristics), and ciprofloxacin hydrochloride (an antibacterial fluoroquinolone), as a dry powder inhaler (DPI) formulation for inhalation. Single and combination powders were produced by spray drying ciprofloxacin and mannitol, from aqueous solution, at different ratios and under controlled conditions, as to obtain similar particle size distributions. Each formulation was characterised using laser diffraction, scanning electron microscopy, differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and colloidal force microscopy. The in vitro aerosol performance of each formulation was studied using an Aerolizer (R) DPI device and a multi-stage liquid impinger (analysed using high performance liquid chromatography). In addition, a disk diffusion test was performed to assess the in vitro antimicrobial activity of each formulation and starting materials. All formulations had similar particle size distributions, however, the morphology, thermal properties and moisture sorption was dependent on the relative percentages of each component. In general, the combination formulation containing 50% (w/w) mannitol appeared to have the best aerosol performance, good stability and lowest particle cohesion (as measured by colloid probe microscopy). Furthermore, of the formulations tested, mannitol did not appear to alter the effectiveness of the ciprofloxacin antimicrobial activity to Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyogenes. The combination of co-spray-dried mannitol and ciprofloxacin from a DPI is an attractive approach to promote mucous clearance in the respiratory tract while simultaneously treating local chronic infection, such as chronic obstructive pulmonary disease and cystic fibrosis. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 66 条
[31]   INVITRO ASSESSMENT OF COMBINED ANTIBIOTIC AND MUCOLYTIC TREATMENT FOR PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS [J].
HEAF, DP ;
WEBB, GJ ;
MATTHEW, DJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1983, 58 (10) :824-826
[32]   Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus [J].
Heijerman, Harry ;
Westerman, Elsbeth ;
Conway, Steven ;
Touw, Daan ;
Doring, Gerd .
JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (05) :295-315
[33]  
HORDVIK NL, 1985, AM REV RESPIR DIS, V131, P889
[34]   The characterization and comparison of spray-dried mannitol samples [J].
Hulse, Wendy L. ;
Forbes, Robert T. ;
Bonner, Michael C. ;
Getrost, Matthias .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (06) :712-718
[35]   Dornase alfa for cystic fibrosis [J].
Jones, Ashley P. ;
Wallis, Colin .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03)
[36]   Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3 [J].
Kellerman, Donald ;
Mospan, Andrea Rossi ;
Engels, Jean ;
Schaberg, Amy ;
Gorden, JoAnn ;
Smiley, Lynn .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (04) :600-607
[37]   PULMONARY-FUNCTION AND CLINICAL COURSE IN PATIENTS WITH CYSTIC-FIBROSIS AFTER PULMONARY COLONIZATION WITH PSEUDOMONAS-AERUGINOSA [J].
KEREM, E ;
COREY, M ;
GOLD, R ;
LEVISON, H .
JOURNAL OF PEDIATRICS, 1990, 116 (05) :714-719
[38]   The physical state of mannitol after freeze-drying: Effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute [J].
Kim, AI ;
Akers, MJ ;
Nail, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (08) :931-935
[39]   Safety of aerosolized amphotericin B [J].
Knechtel, Stephanie A. ;
Klepser, Michael E. .
EXPERT OPINION ON DRUG SAFETY, 2007, 6 (05) :523-532
[40]   EFFECT OF HIGH-DOSE IBUPROFEN IN PATIENTS WITH CYSTIC-FIBROSIS [J].
KONSTAN, MW ;
BYARD, PJ ;
HOPPEL, CL ;
DAVIS, PB .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :848-854